Core A- Administration, Education, and Mentoring
Core A- Administration, Education, and Mentoring
批准号:
10553865
负责人:
MICHAEL R GARRETT
金额:
$56.84万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-06 至 2028-02-29
关键词:
AddressAdvisory CommitteesAreaBioinformaticsBiometryCause of DeathCenters of Research ExcellenceChargeChronic DiseaseCollaborationsComplementComputational BiologyCore FacilityCreativenessData SetDiabetes MellitusDiseaseDisease ProgressionEarly InterventionEducationEnsureEnvironmentEvaluationExtramural ActivitiesFacultyFeedbackFosteringFundingGenesGenetic Predisposition to DiseaseGenomicsGoalsGrantHealthHeart DiseasesIndividualInfrastructureInstitutionInvestigationKidney DiseasesLeadershipMedicalMedical centerMentorsMentorshipMethodologyMissionMississippiMolecularNational Institute of General Medical SciencesOnset of illnessOrganismPhasePhysiologicalPhysiologyPilot ProjectsPoliciesPopulationProgram DevelopmentProteomicsReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsResearch TrainingSocioeconomic StatusStrokeStructureSystems BiologyTeacher Professional DevelopmentTechnologyTrainingUnited StatesUniversitiesWhole OrganismWorkcareerdiet and exerciseearly-career facultyimprovedindividualized medicineinnovationinsightlipidomicsmeetingsmembermetabolomicsmultidisciplinarynew technologynovelpathogenprogramsrecruittranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core A- Abstract
The goal of the Molecular Center of Health and Disease (MCHD), a new Phase I COBRE, is to facilitate
research under a central theme of molecular physiology to enhance the depth of education, mentorship, and
training of researchers to generate unique opportunities to apply omics technology and computational biology
across the health-disease continuum. While chronic diseases can be treated, an understanding of genetic
susceptibility and molecular mechanisms involved in disease onset has the potential to halt progression and
return an individual to a more healthy state. The integration of genomic, transcriptomic, proteomic, and
metabolomic datasets with physiological information using computational approaches can provide novel insight
into the molecular, cellular, and overall physiology associated with the health-disease continuum. The MCHD
will be comprised of multiple components including an administrative unit, education and mentoring programs, a
pilot project program, two research cores, and three major project investigators. In particular, Core A-
Administration, Education, and Mentoring will be charged with promoting the mission of the MCHD to
facilitate the use of innovative approaches to study health, onset and progression of disease, and interaction
with pathogens, with the goal of understanding the breadth of information from the molecular level to the whole
organism. Core A will provide administrative support, coordinate activities of research cores (including Core B-
Omics and Gene-Editing and Core C-Research Computing, Bioinformatics, and Biostatistics), coordinate
governance activities (executive committee and internal and external advisory committees), develop and
implement education and mentoring programs, facilitate the pilot project program; and work to promote
collaboration with other IDeA supported programs (COBRE, INBRE, and IDeA-CTR). The broad objectives of
the Core A are to: (1) establish and maintain an effective organizational and governance structure to support
state-of-the-art cores essential for MCHD investigators to apply cutting edge omics and computational
approaches to address important scientific questions related to the health and disease continuum; (2) promote
a research environment that is creative, nurturing, collaborative and multidisciplinary by providing education in
omics and computational approaches, supportive mentoring and research funding for major project and pilot
project investigators; (3) identify and implement long-term strategies to maximize sustainability of the MCHD by
seeking quality improvement, implementation of new technology for research innovation, recruitment of new
faculty, and fostering important interactions with other IDeA program. In total, these aims will work synergistically
to develop an innovative, state-of-the-art Phase I COBRE to strengthen institutional infrastructure, provide a
robust research training and mentoring environment for a diverse group of early career investigators with the
common goal of developing a better understanding of molecular underpinnings of health and chronic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Omics, Bioinformatics and Flow Cytometry Core
-
批准号:10630580
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2023
-
负责人:MICHAEL R GARRETT
-
依托单位:
Project 1 - TBD
-
批准号:10553868
-
项目类别:
-
资助金额:$21.1万
-
财政年份:2023
-
负责人:MICHAEL R GARRETT
-
依托单位:
Molecular Center of Health and Disease
-
批准号:10553864
-
项目类别:
-
资助金额:$228.38万
-
财政年份:2023
-
负责人:MICHAEL R GARRETT
-
依托单位:
Core B-Omics and Gene-Editing
-
批准号:10553866
-
项目类别:
-
资助金额:$48.28万
-
财政年份:2023
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetic Targets of Hypertension End Organ Damage
-
批准号:10198017
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2018
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetic Targets of Hypertension End Organ Damage
-
批准号:9920359
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2018
-
负责人:MICHAEL R GARRETT
-
依托单位:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
-
批准号:10403631
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2013
-
负责人:MICHAEL R GARRETT
-
依托单位:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
-
批准号:10159921
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2013
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetics of Renal End Organ Damage in Hypertension
-
批准号:8477235
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2009
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetics of Renal End Organ Damage in Hypertension
-
批准号:8289584
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2009
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetics of Renal End Organ Damage in Hypertension
-
批准号:8123186
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2009
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetics of Renal End Organ Damage in Hypertension
-
批准号:7906923
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2009
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetics of Renal End Organ Damage in Hypertension
-
批准号:7715407
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2009
-
负责人:MICHAEL R GARRETT
-
依托单位:
Genetic Analysis of Renal Disease in SHR and Dahl S Rats
-
批准号:6637544
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2001
-
负责人:MICHAEL R GARRETT
-
依托单位:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
-
批准号:9920748
-
项目类别:
-
资助金额:$36.6万
-
财政年份:--
-
负责人:MICHAEL R GARRETT
-
依托单位:
海外基金